Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III Study of the Efficacy and Safety of Macuclear MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

NCT01601483 is registered in ClinicalTrials.gov with MacuCLEAR, Inc. as lead sponsor.

NCT NCT01601483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01601483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III Study of the Efficacy and Safety of Macuclear MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration
Lead sponsor
MacuCLEAR, Inc.
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2012
Completion date
March 31, 2013
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonexudative age related macular degeneration